The anticoccidial drugs market is anticipated to grow at a modest CAGR of around 4% during the forecast period 2020-2026. Coccidiosis is a parasitic disease which is caused due to coccidian protozoa. The primary symptom of the disease includes diarrhea which may become bloody in severe cases. Coccidiosis is found in dogs, chickens, cattle, goats, and many other species. Sometimes, there is also a risk of transferring this disease to humans through dogs. Besides, it is one of the most common diseases among chickens, especially in young chickens.
A full Report of Global Anticoccidial Drugs Market is Available at: https://www.omrglobal.com/industry-reports/anticoccidial-drugs-market
Increasing meat consumption is a key factor for the growth of the poultry industry all across the globe, which in turn will augment the demand of anticoccidial drugs. The US is the largest poultry market all across the globe. As per the United States Department of Agriculture, the per capita poultry consumption has been increased to more than 51 kg per capita in 2019 as compared to nearly 45 kg per capita in 2010. Flat market growth is expected in 2020, majorly due to COVID-19 pandemic and lockdowns in the country. However, poultry consumption is again expected to increase in 2021 near to 51.5 kg per capita consumption.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/anticoccidial-drugs-market
Besides, the population of the country is also growing with a steady growth rate every year. As per the United Nations, the population of the US has increased to 329 million from 309 million in 2010. Both the factors directly signify the need of anticoccidial drugs in the country to provide healthy poultry meat to the consumers. Boiler chicken is the most consumed poultry meat in the country, with a share of 85% to the overall poultry consumption. During the meantime, consumption of beef, pork has also increased in the country which is another factor augmenting the demand for veterinary drugs for diseases in the cattle.
Some of the other countries with higher meat consumption where anticoccidial drugs will find a significant application include China, the European Union, Brazil, Russia, Mexico, Japan, and India. After the US; China is the largest consumer of chicken meat all across the globe. According to the United States Department of Agriculture, the chicken consumption of the country was 13.9 million tons in 2019 as compared to 11.6 million tons in 2018 followed by Brazil and Russia respectively. Some of the largest global poultry manufacturers include Tyson Foods, BRF, Pilgrim, JBS Aves Brasil, and Wen's Food Group. While, some key anticoccidial drug manufacturer include Zoetis, Inc., Bayer AG, Ceva Santé Animale, Huvepharma EOOD, Merck & Co., Inc., Venkateshwara Hatcheries Pvt. Ltd., Vetoquinol S.A. and Virbac S.A.
Global Anticoccidial Drugs Market- Segmentation
By Drug Type
- Chemical Derivative
By Animal Type
- Companion Animal
Global Anticoccidial Drugs Market– Segment by Region
- Rest of Europe
- Rest of Asia-Pacific
Rest of the World
- Bayer AG
- Bioproperties Pty. Ltd.
- BOEHRINGER Ingelheim International GmbH
- Ceva Santé Animale
- Elanco Animal Health Inc.
- Huvepharma EOOD
- Impextraco N.V.
- Kemin Industries, Inc.
- Merck & Co., Inc.
- Phibro Animal Health Corp.
- Qilu Animal Health Products Co., Ltd.
- Schering-Plough Corp.
- Venkateshwara Hatcheries Pvt. Ltd.
- Vetoquinol S.A.
- Virbac S.A.
- Zoetis, Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/anticoccidial-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404